Provectus Biopharmaceuticals Inc (PVCT)

[Mokyo Toe]

Incidentally, I would like to reply to this (and I was not the one who removed the posts, that must've been iHub mods, I am as tolerant as iHub lets me be)

You have posted almost the same message verbatim on this forum, months ago. I don't know if you follow company news or not, or if you feel burned on the stock, which I can understand.

The company fired the thieves and cooperated with the SEC. The Board of Directors was replaced, and there is a new acting CEO.

The SEC recommends charges against Dees, who also must come up with restitution. The SEC investigation is over, and no actions were taken against PVCT. The SEC praised PVCT for its cooperation.

So, that part of PVCT's history is done and finished, and it looks like somebody is going to jail. But he hasn't had anything to do with PVCT since 2016, and if the SEC says it is in the past, then it is in the past.

So that should answer your first question.

As for the second part of your question, your testimony simply does not jibe with the PV-10 data that has come in, which have exceeded expectations. You present no scientific argument as to why the science is wrong, but the doctors working on the drugs have offered sound scientific evidence why this drug may not just do what it claims, but do it better than expected. PH-10 data has been good too.

At any rate, until Phase III data comes in, you have no real argument. All the other data has been fine.

As for your third point, it is just absurd hyperbole. If anyone put their "savings" into a penny stock of a no-revenue company, then they deserve a hard lesson in real life and they got one. If they are still holding, and averaged down, they are having a very good quarter. If they sold at the bottom, well that's another risk of buying penny stocks.

Hope this answers your questions.